Hi friends , i found this review article very interesting and like to provide some other additional information and Pictures about the topic .I am providing the link for the review article which was published in African Journal of Biotechnology Vol. 8 (12), pp. 2645-2652, 17 June, 2009.
Pdf link of the article
click here www.ajol.info/index.php/ajb/article/viewFile/60807/49020
Picture 2 Camelid (Lama) and Picture 4: cartilagenous Fishes (wobbegong).
Pdf link of the article
click here www.ajol.info/index.php/ajb/article/viewFile/60807/49020
•ABLYNX in Belgium which is a biopharmaceutical company is
engaged in discovery and development of Nanobodies in therapeutic programs including major disease areas such as
thrombosis ,inflammation, oncology and Alzheimer’s disease.
•Ablynx’s vWF Nanobody programme was granted orphan
drug designation by both the U.S. FDA and the European Commission for the
treatment of thrombotic thrombocytopenic purpura (TTP).
•Nanobodies with specificity to other targets of
biological relevance will be another future challenge.
Thanks for sharing the link. You are right, it is very interesting and I found new information about nanobodies as one of the antibody technology. I looking forward for more research you going to share. have a nice! day
ReplyDelete